Ignite Creation Date:
2024-05-06 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04716634
Status:
COMPLETED
Last Update Posted:
2024-03-25
First Post:
2021-01-13
Brief Title:
Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors
Sponsor:
BeiGene
Organization:
BeiGene
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumors |
Keywords:
| Name | View |
|---|---|
| Solid tumors | View |